BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18679415)

  • 1. Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
    Müller DW; Bosserhoff AK
    Oncogene; 2008 Nov; 27(52):6698-706. PubMed ID: 18679415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human let-7a miRNA blocks protein production on actively translating polyribosomes.
    Nottrott S; Simard MJ; Richter JD
    Nat Struct Mol Biol; 2006 Dec; 13(12):1108-14. PubMed ID: 17128272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
    Tsang WP; Kwok TT
    Apoptosis; 2008 Oct; 13(10):1215-22. PubMed ID: 18758960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
    Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
    Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
    Brueckner B; Stresemann C; Kuner R; Mund C; Musch T; Meister M; Sültmann H; Lyko F
    Cancer Res; 2007 Feb; 67(4):1419-23. PubMed ID: 17308078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
    Wang M; Hu Y; Amatangelo MD; Stearns ME
    Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells.
    Wendler A; Keller D; Albrecht C; Peluso JJ; Wehling M
    Oncol Rep; 2011 Jan; 25(1):273-9. PubMed ID: 21109987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
    Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
    Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth.
    Schultz J; Lorenz P; Gross G; Ibrahim S; Kunz M
    Cell Res; 2008 May; 18(5):549-57. PubMed ID: 18379589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.
    Sturm RA; Satyamoorthy K; Meier F; Gardiner BB; Smit DJ; Vaidya B; Herlyn M
    Cancer Res; 2002 Jan; 62(1):226-32. PubMed ID: 11782382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.
    Levati L; Alvino E; Pagani E; Arcelli D; Caporaso P; Bondanza S; Di Leva G; Ferracin M; Volinia S; Bonmassar E; Croce CM; D'Atri S
    Int J Oncol; 2009 Aug; 35(2):393-400. PubMed ID: 19578755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A miRNA signature of prion induced neurodegeneration.
    Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
    PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA-211 is involved in expression of preferentially expressed antigen of melanoma in melanoma cells.
    Sakurai E; Maesawa C; Shibazaki M; Yasuhira S; Oikawa H; Sato M; Tsunoda K; Ishikawa Y; Watanabe A; Takahashi K; Akasaka T; Masuda T
    Int J Oncol; 2011 Sep; 39(3):665-72. PubMed ID: 21687938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-dependent regulation of cKit in cutaneous melanoma.
    Igoucheva O; Alexeev V
    Biochem Biophys Res Commun; 2009 Feb; 379(3):790-4. PubMed ID: 19126397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
    Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
    Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. let-7 regulates Dicer expression and constitutes a negative feedback loop.
    Tokumaru S; Suzuki M; Yamada H; Nagino M; Takahashi T
    Carcinogenesis; 2008 Nov; 29(11):2073-7. PubMed ID: 18700235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.